Yu Jiao Wang

Epitomics, Inc. an emerging biotechnology company, is dedicated to developing their breakthrough monoclonal antibody technology (RabMAb®) for research, diagnostics and therapeutics. The Company has utilized a unique and proprietary RabMAb technology invented by scientists at Loyola University of Chicago and the University of California at San Francisco. This enabling platform produces high quality antibodies that have the potetial to be used in the broad areas of research, diagnostics and therapeutics. Compared to currently available monoclonal antibody technology, such as mouse hybridomas, the company's proprietary technology can generate RabMAbs more efficiently and with superior binding affinity and bioactivity in a wide variety of biological assays. The high throughput and robust nature of the technology allows for the simultaneous discovery of disease targets and potential therapeutic antibodies in the same experiments, significantly shortening the drug discovery and development cycle. The company aims to become the largest provider of monoclonal antibody technology through developing and commercializing their RabMAb technology and products in research, diagnostics, and therapeutics. The firm is headquartered in Burlingame, California and operates a wholly owned subsidiary in Hangzhou, the People's Republic of China.

Part of Arkema SA, Shanghai Arkema Gaoyuan Chemical Co. Ltd. is a producer of high performance materials, industrial specialties, and coating solutions. The company is based in Shanghai, China. The Chinese French company Arkema established its presence in China in 1984 and became an independent group in 2004 after the reorganization of the chemical branch of Total. Arkema is a diversified chemicals manufacturer that focuses on finding solutions to the challenges the world is facing today, which is a source of growth and a strategic pillar of its organization.

MIXUE Group engages in the production of freshly-made drinks. It offers fruit drinks, tea drinks, ice cream, and coffee under the brands of Mixue and Lucky Cup. The company was founded by Hong Chao Zhang and Hong Fu Zhang in 1997 and is headquartered in Zhengzhou, China.

The Chartered Governance Institute provides governance and compliance services. The company was incorporated by Royal Charter in 1891 and is headquartered in London, the United Kingdom.

Ifenqu Network Technology Shanghai Co. Ltd. operates radio, television, and electronic stores. The private company is based in Shanghai, China. The Chinese company was founded by Wei Dong Lin.

Shanghai MUHE Network Technology Co., Ltd. provides gaming software development services. The private company is based in Shanghai, China.

Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China.

Taizhou Oriental China Medical City Holding Group Co. Ltd. provides investment services. The private company is based in Shanghai, China.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Shanghai Yang Guofu Enterprise Management (Group) Co., Ltd. engages in food and beverage business. It is operating through Franchised Restaurants, Self-operated Restaurants, and Others segments. The company was founded on November 5, 2015 and is headquartered in Shanghai, China.

Tricor Services Ltd. provides accounting and consulting services. The company is headquartered in Hong Kong.

QuanDx, Inc. provides molecular diagnostics. It specializes in the development and commercialization of novel diagnostic tools. The firm provides diagnostic and prognostic information for hematological and solid tumor cancers, as well as a number of infectious diseases. The company was founded by Matthew Lei and Guo-Liang Yu in 2012 and is headquartered in San Jose, CA.

Mendel Biotechnology, Inc. operates as a plant biotechnology company. It develops genetic and chemical solutions for a range of agricultural markets. The firm offers biofuel feedstocks, yield enhancement, flowering, drought tolerance, freezing tolerance, disease resistance, nutrient use efficiency, and cold germination products. The company was founded in 1997 and is headquartered in Newark, CA.

Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD.

Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA.

The Chinese-American Biopharmaceutical Society is a non-profit organization for professionals in the biopharmaceutical industry. The non-profit company is based in San Francisco, CA, the birthplace of biotechnology and one of the largest biomedical hubs in the world. The company's membership consists of life science professionals from a broad range of experience levels, with a large percentage of members holding senior or executive positions in the industry. The society offers year-round sponsorship opportunities, including the highly anticipated 2023 annual BioPacific Conference, and leverages an extensive network of life sciences professionals.

The National Foundation for Cancer Research is a non-profit organization that provides funding to scientists for cancer research. The non-profit company is based in Bethesda, MD. The company's mission is to support life-saving discoveries for cancer patients.

University of the Pacific is a nationally ranked university with a long tradition of dedicated teaching, small class sizes, practical experience and vibrant residential life. The breathtaking main campus in Stockton, California is home to seven schools and colleges, with more than 80 majors and programs of study. Pacific also has the McGeorge School of Law in Sacramento and the Arthur A. Dugoni School of Dentistry in San Francisco. Total university enrollment is nearly 7,000, with 3,757 undergraduates in an average class size of 19 and a student/faculty ratio of 14:1. It is located in Stockton, California.

OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London.

Apollomics, Inc. operates as a sciences oncology company. It is a biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company was founded by Sanjeev Gurunath Redkar and Guo-Liang Yu on May 21, 2015 and is headquartered in Foster City, CA.

Immune-Onc Therapeutics, Inc. operates as a biopharmaceutical company focused on developing innovative therapeutic antibodies for cancer treatment. The company was founded by Charlene Liao and Gui-Liang Yu in 2016 and is headquartered in Palo Alto, CA.

NVIGEN, Inc. develops multifunctional and biodegradable nanoparticles. Its products include MagVigen, MaxVigen, MyQuVigen, and AuVigen. The company was founded by Aihua Fu and Guo Liang Yu and is headquartered in Campbell, CA.

Applied StemCell, Inc. is a biotechnology company. Its products include stem cell research, genome editing products for cell line generation, primary cells from patient samples and isogenic cell lines. The company was founded by Ruhong Jiang, Ruby Yanru Chen-Tsai and Michael Cleary and is headquartered in Milpitas, CA.